IL10 and non-small cell lung carcinoma: A NSCLC clinical study found that a subset of tumor-infiltrating B7-H3+ CD14+ HLA-DR−/low M-MDSCs secrete elevated amounts of IL10 and are associated with reduced recurrence-free survival [141].